Erythroid myeloid lymphoid (EML) cells are an established multipotent hematopoietic precursor cell line that can be maintained in medium including stem cell factor (SCF). EML cultures contain a heterogeneous mixture of cells, including a lineage-negative, CD34 + subset of cells that propagate rapidly in SCF and can clonally regenerate the mixed population. A second major subset of EML cells consists of lineage-negative. CD34
− cells that can be propagated in IL-3 but grow slowly, if at all, in SCF, although they express the SCF receptor (c-kit). The response of these cells to IL-3 is stimulated synergistically by SCF, and we present evidence that both the synergy and the inhibition of c-kit responses may be mediated by direct interaction with IL-3 receptor. Further, the relative level of tyrosine phosphorylation of various substrates by either cytokine alone differs from that produced by the combination of the two cytokines, suggesting that cell signaling by the combination of the two cytokines differs from that produced by either alone.
T he erythroid myeloid lymphoid (EML) cell line is a multipotent hematopoietic cell line that can be differentiated in vitro into cells of various lineages including erythroid, myeloid, or lymphoid cells (1) . EML cells were derived originally by transfection of murine bone marrow with a dominant negative retinoic acid receptor and then selecting for cells that expanded in medium containing stem cell factor (SCF). EML cells can be subcloned as single cells that expand to produce populations with the same properties as the original culture and can be passaged repeatedly without losing their multipotency. Thus, these cells provide an interesting model of a self-renewing and spontaneously differentiating, niche-independent cell system.
A suspension culture of EML cells passaged in SCF contains a complex mixture of cells at various stages of differentiation. The lineage-negative portion of the culture can be separated roughly into a CD34 + , stem cell antigen 1 (Sca-1)-high population and a CD34 − , Sca-1-low population. The CD34 + subfraction of the cells grows rapidly in medium containing SCF, reconstituting a mixed population of EML cells. Growth of these cells is stimulated synergistically by IL-3, a cytokine capable of stimulating growth of a variety of hematopoietic cell types, but the cells will not grow in IL-3 medium without SCF. Conversely, the CD34 − , lineage-negative cells grow in IL-3 medium, and growth is stimulated synergistically by SCF, but this fraction of cells will not grow, or grows only very slowly, in SCF alone (2) .
The SCF receptor c-kit is a member of the tyrosine kinase receptor family (3) . SCF plays critical roles in regulating the renewal, growth, and differentiation of hematopoietic stem cells (4) (5) (6) (7) . SCF activates a tyrosine phosphorylation cascade mediated by c-kit resulting in the creation of a complex network affecting multiple biological processes (5, 8, 9) . The synergy of SCF with other growth factors or cytokines initiates specific differentiation of hematopoietic stem cells into definite lineages (10) (11) (12) . The IL-3 receptor (IL-3R) also is a tyrosine kinase consisting of a heteromer of two types of chains, a common β chain shared with the IL-5 receptor and GM-CSF receptor, and an IL-3-specific α chain (13) . Changes in tyrosine phosphorylation of c-kit or the IL-3R β chain parallel the effects of the cytokines on cell growth and show clearly the synergistic effect of treatment of either CD34 + or CD34 − cells with a combination of the two cytokines. Remarkably, this differential response to cytokines occurs even though the CD34 + and CD34 − lines have about equal amounts of c-kit mRNA, and c-kit protein is present and expressed on the cell surface in about equal amounts in the two cell populations (2) .
In the present study we confirmed the synergistic action of IL-3 and SCF and show this synergy can occur in nonhematopoietic cells after transfection of the appropriate receptors. We also found that an excess of the IL-3R α chain can prevent c-kit response to SCF. Proteomic analysis of tyrosine phosphorylation products shows that many of the tyrosine phosphorylation events occur with treatment by either cytokine. The results confirm the synergistic action of the two cytokines, but the level of synergistic phosphorylation varies with the substrate, so that treatment with combined cytokines could create a balance of phosphorylated substrates different from that produced by treatment with either cytokine alone.
Results
Dynamic Phosphorylation of c-kit and Akt. Stimulation of SCF leads to dimerization of the c-kit receptor and subsequent activation of its intrinsic tyrosine kinase (14) . The phosphorylation of c-kit happens rapidly, and the activated c-kit is internalized, followed by degradation mediated by the ubiquitin pathway (15) . To test the dynamic phosphorylation of c-kit and thymoma viral protooncogene 1 (Akt), we checked phosphorylation of c-kit and Akt under different stimuli at several time points. As shown in Fig. 1 , strongly phosphorylated c-kit and Akt were detected as early as 2 min after stimulation. Transphosphorylation of c-kit induced by IL-3 was observed at early time points. Compared with SCF, IL-3 induced less phosphorylated c-kit or Akt. The PI3K-Akt pathway plays critical roles in regulating cell proliferation and differentiation (16) . The differential phosphorylation of c-kit and Akt induced by IL-3 and SCF was consistent with the different proliferation response of EML cells to the two cytokines. The most intensely phosphorylated c-kit was detected at 5 min. Akt was maximally phosphorylated at 2 min. Synergy between SCF and IL-3 was prominent and also was seen early after cytokine treatment, peaking by 5 min.
Our previous data showed synergistic phosphorylation and transphosphorylation between c-kit and the IL-3R β chain in lineage-negative EML cells. Because the phosphorylation of c-kit is dynamic, we also checked phosphorylation of c-kit with different doses of SCF at 5 min. As shown in Fig. 2 , a low dose of SCF induced phosphorylation of c-kit at 5 min. The phosphor-ylation of c-kit was increased as the SCF concentration increased up to but not beyond 50 ng/mL Phosphorylated c-kit decreased with the highest dose of SCF (100 ng). The synergistic phosphorylation of c-kit, Akt, Mek, and Erk by IL-3 and SCF also was observed with lower doses of SCF. Synergistic phosphorylation of the IL-3Rβ also occurred when SCF and IL-3 were added together to cells (Fig. 3 ).
Antibody Ab-1 Eliminates Synergistic Proliferation and Phosphorylation of c-kit by SCF and IL-3. We confirmed that synergistic proliferation of EML cells is induced by the combination of SCF and IL-3. The cell proliferation induced by SCF was eliminated when the cells were pretreated by the inhibitory antibody Ab-1. Antibody Ab-1 targets the fourth Ig domain of c-kit and is a dimerizationinhibitory monoclonal antibody. Ab-1 inhibits the phosphorylation of c-kit induced by SCF by preventing c-kit dimerization. Synergistic proliferation also was inhibited by antibody Ab-1. EML proliferation induced by IL-3 was not inhibited significantly by antibody Ab-1 (P > 0.05) (Fig. 4A) . To investigate further the mechanism behind the synergistic effects on proliferation, we checked the activation of the PI3K-Akt and MAPK-ERK pathways in EML cells with different treatments. The PI3K-Akt and MAPK-ERK pathways are critical for inducing cell proliferation and inhibiting cell apoptosis (16) (17) (18) . Significant synergistic phosphorylation of c-kit, Akt, mitogen-activated protein kinase kinase 1 (Mek), and mitogen-activated protein kinase 1 (ERK) induced by SCF plus IL-3 was observed (Fig. 4B) . The antibody Ab-1 not only inhibited phosphorylation of c-kit, Akt, Mek, and ERK by SCF alone but also eliminated synergistic phosphorylation of these proteins by the combination of SCF and IL-3. These results indicate that the synergy between c-kit and IL-3R is dependent on the c-kit dimerization domain, if not on the dimerization of c-kit itself. Surprisingly, the pretreatment with Ab-1 induced detectable phosphorylation of Akt, Mek, and ERK compared with an IgG control. Ab-1 is not able to inhibit the transphosphorylation of c-kit induced by IL-3. Therefore, the low level of c-kit phosphorylation induced by IL-3 did not occur through c-kit kinase activation.
c-Kit and IL-3 Receptor Form a Complex in EML cells. After confirming the synergistic activation of c-kit by SCF and IL-3, we were interested in the mechanisms underlying the synergy. The association of c-kit and the erythropoietin receptor (EpoR) leads to the synergistic activation and trans-activation between these two receptors (10) . To determine if c-kit associates with IL-3R, we immunoprecipitated c-kit or IL-3Rβ from EML cells. The immunocomplex was resolved using SDS/PAGE and transferred onto an Immobilon P membrane. As shown by Fig. 5A , antibody specific for c-kit immunoprecipitated both c-kit and IL-3Rβ. The antibody for IL-3Rβ also coimmunoprecipitated IL-3Rβ and c-kit. To investigate further if the complex of c-kit and IL-3Rβ is dependent on the stimulation of the cytokines, we immunoprecipitated c-kit or IL-3Rβ from EML cells without treatment or with different treatments. As shown by Fig. 5D , c-kit is constitutively associated with IL-3Rβ even without stimulation by cytokines. To confirm the specificity of the coimmunoprecipitation, we checked other proteins known to be associated with c-kit in the pellets of the complex immunoprecipitated with c-kit antibody. PI3K is present in the pellets, but PDGF receptor (PDGFR) was absent. IL-3Rα also was detected in the immunoprecipitation complex obtained with c-kit antibody (Fig. 5D ).
Synergy Between IL-3 and SCF also Can Be Demonstrated in a Nonhematopoietic Cell in the Presence of the Appropriate Receptors. To check whether the synergistic phosphorylation of c-kit induced by SCF and IL-3 is specific to a hematopoietic cell line, we cotransfected a human embryonic kidney cell line, 293T, with c-kit and IL-3R (α chain and β chain). There was no detectable endogenous c-kit or IL-3R in 293T cells, but both receptors were detected on the surface of 293T cells transfected with the relevant expression plasmids. As shown in Fig. 6 , the combination of IL-3 and SCF induced a significant synergistic phosphorylation of c-kit in 293T cells. The data indicated that the synergistic activation of c-kit induced by IL-3 and SCF is not limited to EML cells.
Overexpressed IL-3Rα Inhibits Activation of c-kit. The data profile of RNA expression in lineage-negative, CD34
+ and lineagenegative, CD34
− EML cells showed that the expression of IL-3Rα in lineage-negative, CD34
− cells was around threefold that of lineage-negative, CD34 + cells. We confirmed the microarray data by Western blotting, shown in Fig. 7A . In our previous studies we found the growth of lineage-negative, CD34
− cells did not respond to SCF even though the levels of c-kit mRNA, protein, and surfaced antigen expression are rather similar in the CD34 − and CD34 + cells (2) . We asked whether the overexpression of IL-3Rα inhibits c-kit signaling. To answer this question, we transduced EML cells with lentivirus particles expressing the α chain or β chain of IL-3R fused with internal ribosome entry site (IRES)-GFP. Surprisingly, no GFP + cells were detected in EML cells transduced by IL-3Rα-IRES-GFP. Approximately 20% GFP + cells were present in EML cells transduced with equal amounts of virus particles expressing IRES-GFP control or IL-3Rβ-IRES-GFP, as shown in Fig. 7B . These data suggested that 2 min 5 min 10 min 20 min overexpression of IL-3Rα is toxic to EML cells, perhaps by depriving the cells of SCF stimulation. To confirm this hypothesis, we transformed c-kit and IL-3Rα into 293T cells and checked if overexpressed IL-3Rα inhibits phosphorylation of c-kit in a non-EML cell. As shown in Fig. 7C , the phosphorylation of c-kit induced by SCF was reduced when the IL-3Rα and c-kit were added to the cells. These results indicated that the programmed response of hematopoietic precursors to SCF might be determined by quantitative changes in gene expression of the relevant receptors. The results showed, as expected, that there was a considerable overlap between proteins phosphorylated in response to IL-3 or to SCF (Table S1 ). Because of the limits in sensitivity of mass spectroscopy, we cannot conclude that proteins detected with only one of the two treatments were differentially phosphorylated in response to one or the other cytokine. However, there was prominent difference in the amount of synergistic phosphorylation of different substrates compared with the effect of either cytokine alone. For example, both c-kit and inositol polyphosphate-5-phosphatase D (INPP5D) showed markedly increased levels of phosphotyrosine when cells were treated with the combination of the two cytokines, but a number of other substrates showed essentially no difference in phosphorylation when the cells were treated with the two combined cytokines or with either one alone. SILAC profile patterns of phosphorylation of the key proteins mediating phosphatidylinositol 3′-kinase and Ras/MAPK pathways are consistent with the Western blotting data.
Discussion EML cells consist of a heterogeneous population that will propagate in medium containing SCF. The CD34 + , lineage-negative subset of EML cells is the only substantial subset of cells that grows rapidly in SCF medium in the absence of other cytokines. This observation strongly suggests that the CD34 + population rapidly regenerates the mixed culture in response to SCF. Although this subset of cells expresses both subunits of IL-3R, the cells are refractory to treatment with IL-3 alone, as seen both in cell growth and in phosphorylation of IL-3R.
The CD34 − cells continue to express levels of c-kit mRNA, total cell protein, and cell-surface protein similar to those of the CD34 + cells. However, the CD34 − cells no longer respond to SCF by receptor phosphorylation or cell growth. In both subsets of EML cells SCF and IL-3R have a marked synergistic effect on cell growth and phosphorylation when the two cytokines are present simultaneously. This effect indicates that in both cell types the receptors remain able to recognize their cognate ligands, although the consequences of this recognition differ drastically, so that SCF stimulates the less differentiated cells and IL-3 the more differentiated cells.
Renewal and expansion in the hematopoietic system depend on cytokines that promote survival and division of cells of various lineages or stages of differentiation (19) (20) (21) . In particular, SCF promotes the expansion of early hematopoietic precursor cells, whereas IL-3 is a multilineage cytokine that stimulates growth of early, partly differentiated cells (7, 22, 23) . The effects of these cytokines on EML cells is consistent with this difference, because the population of lineage-negative, CD34
+ cells shows lower levels of expression of a number of lineage-specific genes, and IP: IL-3R Fig. 3 . Phosphorylation of the IL-3R β chain induced by IL-3, SCF, or IL-3 plus SCF. EML cells were starved for 3 h and treated by IL-3 (4 ng/mL), SCF (50 ng/mL), or IL-3 plus SCF for 5 min. The IL-3R β chain was immunoprecipitated with antibody for IL-3Rβ, and the immunoprecipitated pellets were resolved by SDS/PAGE and electrotransferred to Immobilon P, followed by immunoblotting with the indicated antibodies. The results show that SCF acts synergistically with IL-3 to phosphorylate the IL-3R β chain. This effect was particularly prominent for serine phosphorylation. IL3-Rβ, common β-chain IL-3R; pS, phosphorylated serine; pY, phosphorylated tyrosine. Cell number(x10 5 )
IgG(5ug/ml) Ab-1(5ug/ml) IL-3(2ng/ml) SCF(50ng/ml) The receptor c-kit has been known for some time to interact with certain other tyrosine kinase receptors including EpoR, GM-CSF receptor (GM-CSFR), and IL-7 receptor, and this physical interaction may be associated with cross-phosphorylation of c-kit by erythropoietin (EPO) or other cytokines (24) (25) (26) (27) . The physiologic significance of this cross-phosphorylation has been questioned previously.
In our studies we did observe ligand-independent coimmunoprecipitation of c-kit and IL-3R and some cross-phosphorylation between the two receptors. However, the level of phosphorylation of the second receptor was quite low and may not be of physiologic significance. In contrast, there was a marked synergistic effect in both cell growth and tyrosine phosphorylation both in cells responsive to SCF alone and in other cells (the CD34 − subpopulation) that showed neither c-kit phosphorylation nor growth response to SCF. The synergy in tyrosine phosphorylation could be reproduced in a nonhematopoietic human embryonic kidney cell line, so that other hematopoiesis-specific proteins are not necessary for the effect. Synergy did require the presence of both the α and β chains of IL-3R as well as c-kit.
The shift of c-kit-expressing cells to a state unresponsive to SCF without down-modulation of the SCF receptor correlates with the extent of differentiation of the EML cells, providing a mechanism that permits selective expansion of stem cells that may differentiate spontaneously without expanding the more differentiated precursors. At the same time, the synergistic effects would mean that the later precursor cells become sensitive to small amounts of IL-3. The transfection studies with 293T cells suggest that one mechanism for suppressing the response of c-kitexpressing cells to SCF would be mediated by an excess of the IL-3 α chain, although it is possible that other mechanisms may contribute in the EML cells. A similar phenomenon was observed for the interaction of c-kit with the α chain of GM-CSF and EpoR. GM-CSF and SCF synergized in activating the MEK-ERK pathway, but overexpression of the α chain of GM-CSFR inhibited c-kit phosphorylation by SCF (28) . The combination of SCF and EPO synergistically phosphorylates c-kit and EpoR (10, 25) . However, in a leukemic proerythroblast, EPO induces silencing of c-kit making the cells EPO dependent (29) , so different mechanisms may operate in controlling cytokine responsiveness at the receptor level in different types of cells. Those data suggest the balance of different cytokine receptors plays an important role in lineage proliferation, differentiation, and maturation of hematopoietic progenitors. We may speculate that, in the absence of IL-3, the IL-3R α chain directly locks the SCF receptor in a nonresponsive configuration, and this block is relieved when IL-3 binds to its receptor, although the two receptors remain associated with one another. The shift from SCF to IL-3 responsiveness could simply be a mechanism for limiting growth and cytokine responsiveness to less differentiated cells in the absence of IL-3 or also could change the types of signals the cell receives from the cytokine environment (30) . Study of phosphotyrosine protein formation in response to short periods of cytokine treatment, using the SILAC procedure, provides clues in this regard (31, 32) . Reassuringly, the SILAC data show preferential IL-3R β-chain phosphorylation by IL-3, c-kit phosphorylation by SCF, and increased phosphorylation of these receptors when both cytokines are added.
An unexpected phenomenon emerged from analysis of tyrosine phosphorylation. The synergistic effect of c-kit and IL-3 was evident in the increased phosphorylation of c-kit in the presence of IL-3 together with SCF. Some other proteins, such as INPP5D (SH2-containing inositol phosphatase 1, SHIP), showed a similar synergistic phosphorylation. However, there was a group of proteins in which the phosphotyrosine level did not differ significantly whether SCF alone or SCF plus IL-3 was used to stimulate the cells. Thus, the synergistic effect, which is substantially stronger than the effect of either cytokine separately, is not merely an augmentation of responsiveness but shows a different spectrum of phosphorylation stimulation, limited to a subset of genes responding to either cytokine alone. Overall the synergistic effect is not merely an augmentation of preexisting signaling activity but provides a new pattern of relative abundance of phosphotyrosines in the cell and potentially an additional level of complexity in the response patterns of cells to cytokine stimulation.
Methods
Cell Lines, Cytokines, Antibodies, and Other Agents. EML C1 cells were the kind gift of Dr.Schickwann Tsai (University of Utah Health Care) and were cultured as described in the literature (1) . The 293T cells were purchased from ATTC and cultured according to the ATCC instructions. Purified recombinant mouse stem cell factor (rmSCF) and purified recombinant mouse interleukin-3 (rmIL-3) were purchased from Peprotech. Antibodies specific for phosphorylated c-kit at Tyrosine 719 [p c-kit (Tyr719)], phospho-p44/42 MAPK (Thr202/Tyr204), phospho-Akt (Ser473), phospho-Akt (Thr308), and antibodies against total c-kit, p44/42 MAPK, Akt, and the PI3K-specific inhibitor LY294002 were purchased from Cell Signaling Technology. Antibodies against the IL-3R α chain (IL-3Rα), IL-3R β chain (IL-3Rβ), phospho-tyrosine, and the p85 subunit of PI3K were purchased from Santa Cruz Biotechnology. (IL-3Rβ) antibody, and APC-conjugated CD117 (c-kit) antibody were purchased from eBioscience.
Immunoprecipitation, Total Cell Lysate, and Immunoblotting Assay. EML cells were deprived of SCF and horse serum for 4 h, and 293T cells were deprived of serum for 6 h. This deprivation period was followed by the addition of SCF (50 ng/mL) or IL-3 (4 ng/mL) or the combination of SCF and IL-3. The cells were induced for the indicated times and then were collected and washed with PBS buffer and lysed at 1 × 10 7 cells/mL with ice-cold lysis buffer A (lysis buffer for total cell protein analysis) or lysed at 1 × 10 7 cells/mL with ice-cold lysis buffer B (lysis buffer for immunoprecipitation) as described previously (24) . For immunoprecipitation, the lysates were cleared by centrifugation before antibody application. c-Kit, IL-3Rα, or IL-3Rβ was immunoprecipitated from the cleared lysates with their respective antibodies at 1:50 dilution. The immunoprecipitated complex or total cell lysates were subjected to SDS/PAGE, and Western blotting was performed on a PVDF membrane (Millipore) according to the indicated manufacturers' instructions for primary antibodies.
Cell Transfection and Transduction. For stable transfection, cDNA encoding IL-3Rα, the common β chain (IL-3Rβc), or the β chain for IL-3 receptor (IL-3Rβil-3) was cloned into the self-inactivating lentiviral vector plasmid pGK-IRES-GFP. Lentiviral particles were generated by the methods described in ref. 33 Complete replacement with heavy arginine and lysine was confirmed by mass spectrometry after six passages. After six passages, 20 million EML cells growing in light and heavy media were harvested, washed twice, and then starved for 4 h in light or heavy medium without dialyzed FBS or cytokines. After stimulation with SCF (50 ng/mL), IL-3(4 ng/mL), or a combination of SCF (50 ng/mL) and IL-3(4 ng/mL) for 5 min, the cells were harvested and lysed in 100 μL modified RIPA buffer. Equal amounts of cellular lysates from the light and heavy media were mixed together. Total proteins with phosphotyrosine were precipitated following the protocol described in ref. 34 . The phosphotyrosine proteins were released from the immunoprecipitated pellet by heating (95°C for 5 min) and were separated by SDS/PAGE. After SDS/PAGE, the gel was stained with SimplyBlue SafeStain (Invitrogen). Each lane containing proteins was sliced into 15 pieces. The proteins in the sliced gel were extracted and digested. The peptides were enriched by TiO 2 chromatography and processed for LC-MS.
